The leading API biopharma company Concord Biotech IPO will be hit the market Soon. The Company has filed the DRHP of this IPO. According to DRHP, the company wants to raise ₹- crore through IPO. The company will issue fresh shares of ₹- crores through this IPO and will issue shares through offer for sale of 20,925,652 Shares.The company has reserved 50% for QIB, 35% for retail and 15% for NII in this IPO.
■ Update :
- The Company has filed the DRHP of this IPO dated (14 August 2022).
Concord Biotech Limited is a leading vertically integrated, R&D driven biotechnological powerhouse that manufactures Active Pharmaceutical Ingredients through fermentation & semi-synthetic process and Finished formulations. Concord Biotech Limited is a India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in market share. You can check here to know Concord Biotech IPO GMP and Concord Biotech IPO subscription status here.
The company supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India. The company commanded a market share of over 20% by volume in 2021 across identified fermentation-based API products, including dactinomycin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine. As of March 31, 2022, The company had a total installed fermentation capacity of 1,250 m3 . In 2016.
The company launched our formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States. Concord offers world-class API production infrastructure at Dholka located near Ahmedabad, Gujarat, India which is spread across 114,000 sq. meters. Concord is a hub to the largest number of Bioreactors in India with fermentation capacity of more than 500 m3.
|Read also: Upcoming IPO List 2022|
The manufacturing facility complies with cGMP and has been Inspected by global regulatory agencies like U.S. Food & Drug Administration (USFDA), European Union Goods Manufacturing Practice (EUGMP), Japanese Accreditation of Foreign Manufacturers (AFM), Korean Food & Drug Administration & State Goods Manufacturing Practice of India (GMP). Concord has commercialized APIs across niche therapeutic segments like Immunosuppressant, Hematology, Oncology, Anti-fungal, Antibacterial and Anthelmintic (Animal health)
The company annual installed production capacity of our formulation manufacturing facility in Valthera amounted to 522.64 million units, with an average dosage capability of 0.17 million tablets, 0.36 million capsules and 646.46 bottles of dry syrup per shift, which is defined as eight hours of production.
Object Of the Issue :
- The portion with regard to Offer for Sale shall be borne by the Selling Shareholder.
- The Offer is an offer for sale and our Company will not receive any proceeds from the Offer, our Company is not required to appoint a monitoring agency for the Offer.
Company Strengths :
- Established presence across the complex fermentation value chain.
- Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas.
- Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities.
- Diversified global customer base with long-standing relationships with key customers.
- Experienced Promoters, management team supported by marquee investors.
- Financial track record of rapid growth and consistent profitability with healthy cash flows and strong shareholder returns.
Concord Biotech IPO Review :
■ Coming Soon
Concord Biotech IPO Date & Price Band & Details :
|IPO Open :||Update Soon|
|IPO Close :||Update Soon|
|IPO Size :||₹. Cr|
|Face Value :||₹. Equity Share|
|Price Band :||₹ – ₹ Per Share|
|Listing On :||BSE, NSE|
|Issue Size :||₹. Cr|
|Fresh Issue :||₹. Cr|
|Offer For Sale :||₹. Cr|
Concord Biotech IPO Market Lot :
Concord Biotech IPO Minimum Market lot is – Lot with – shares with ₹- Application amount. The retail investors can apply up to – lots with – Shares or ₹- amounts.
|Minimum Lot Size :||– Lot|
|Minimum Share :||– Shares|
|Minimum Amount :||₹-|
|Maximum Lot Size :||– Lot|
|Maximum shares :||– Shares|
|Maximum Amount :||₹-|
Concord Biotech IPO Shares Offer :
A Total of 20,925,652 shares are to be bid for the public issue by Concord Biotech IPO with – for Fresh issue and 20,925,652 for offer for sale Shares.
|Fresh issue :||–||₹–|
|Offer For Sale :||20,925,652||₹–|
Concord Biotech IPO Reservation :
Concord Biotech IPO Total Reservation of 20,925,652 shares are to be bid for the public issue by Concord Biotech IPO with – for QIB and – for NII – For RII & – Shares EMP.
|EMP :||– %||–||₹-|
Concord Biotech IPO EPS :
The Concord Biotech company’s EPS growth is Increasing every year, which is shown to you in the table here.
|Year||EPS Growth in (Rs.)|
Concord Biotech IPO Peer Comparison PE :
The Concord Biotech, According to DRHP of the company some company is listed whose PE Multiple is shown in this table.
|Sr. No.||Company||PE Ratio|
|1.||Divi’s Laboratories Limited||35.31|
|2.||Suven Pharmaceuticals Limited||26.95|
|3.||Laurus Labs Limited||35.90|
|4.||Shilpa Medicare Limited||56.44|
Concord Biotech IPO Dates :
Concord Biotech IPO Date is Announced Soon. The allotment will be finalized on Announced Soon and the IPO may list on Announced Soon.
|Open Date :||Announced Soon|
|Close Date :||Announced Soon|
|Allotment Date :||Announced Soon|
|Refund Date :||Announced Soon|
|Share Credit Date :||Announced Soon|
|Listing Date :||Announced Soon|
Concord Biotech IPO Form :
There are two ways to apply in Concord Biotech IPO. You can apply for Concord Biotech IPO through ASBA available in your bank account. You have to go to your online bank login and select Concord Biotech IPO in the Invest section and apply through your bank account. Another option is you can apply for Concord Biotech IPO through IPO form download through NSE and BSE. See the Concord Biotech IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.
Concord Biotech Company Financial Report (millions) :
Company Promoters :
■ Sudhir Vaid
Quick Link :
■ DRHP Draft Prospectus
■ RHP Draft Prospectus
Concord Biotech IPO Lead Managers :
■ Kotak Mahindra Capital Company Limited
■ Citigroup Global Markets India Private Limited
■ Jefferies India Private Limited
Concord Biotech IPO Registrar :
Link Intime India Private Limited
C 101, 247 Park
L.B.S. Marg, Vikhroli (West)
Tel: +91 22 4918 6200
E-mail ID: [email protected]
Investor Grievance E-mail ID: [email protected]
Note: Check Concord Biotech IPO allotment status Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here
Company Address :
Concord Biotech Limited
1482-86 Trasad Road, Dholka
Ahmedabad, Gujarat – 382225
Telephone: 079-6813 8700
E-mail: [email protected]
Concord Biotech IPO FAQs :
What is Concord Biotech IPO?
Concord Biotech IPO is Mainboard IPO. They are going to raise ₹. Crores via IPO. The issue is priced at ₹-₹- per equity share. The IPO is to be listed on NSE, BSE.
When Concord Biotech IPO will open?
The IPO is to open on Announced Soon for QIB, NII & RII.
What is Concord Biotech IPO Size?
Concord Biotech IPO size is ₹- Crores.
What is the Fresh issue size of Concord Biotech IPO?
The Fresh issue size of Concord Biotech IPO ₹- Cr.
What is the Offer For Sale size of Concord Biotech IPO?
The Offer For Sale size of Concord Biotech IPO ₹- Cr.
What is Concord Biotech IPO Price Band?
Concord Biotech IPO Price Band is ₹-₹- Per share.
What is Concord Biotech IPO Minimum and Maximum Lot Size?
The minimum – Shares with ₹- amount while the maximum – shares with ₹-.
What is Concord Biotech IPO Investors Portion?
The investors’ portion for QIB 50%, NII 15%, RII 5%.
What is Concord Biotech IPO Allotment Date?
Concord Biotech IPO allotment date is Announced Soon.
What is Concord Biotech IPO Listing Date?
Concord Biotech IPO listing date is Announced Soon. The IPO to list on NSE, BSE.
How to Apply the Concord Biotech IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Upstox?
Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Groww?
Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
|Concord Biotech IPO GMP: Click Here|
Concord Biotech IPO Subscription: Click Here
Concord Biotech IPO Allotment: Click Here
Concord Biotech IPO Listing: Click Here
All Concord Biotech IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.